Field gene therapy lead (key account manager)
BerlinKrystal Biotech, Inc
...scale facilities, and a unique commercialization model that focuses on the patient's end to end experience. Krystal has received U.S. FDA approval and EU EMEA authorization for the first and only redosable gene therapy treatment, VYJUVEK, for the treatment of Dystrophic Epidermolysis Bullosa (DEB). Krystal continues to leverage [...]
Kategorie Marketing